Tag: Idorsia

Swiss biopharmaceutical firm Idorsia Ltd has successfully concluded a capital increase that exceeded initial expectations, demonstrating robust market confidence. The ...

Investors in Idorsia received an unexpected jolt as the biotechnology firm unveiled plans for a substantial capital increase through an ...

Idorsia Ltd. witnessed an extraordinary trading session yesterday as its stock price skyrocketed without prior indication. The Swiss biotechnology company's ...

Idorsia Ltd. shares are currently caught in a storm of market volatility, with significant price swings and unusually heavy trading ...

Idorsia Ltd. shares are under significant selling pressure in the current trading session, continuing a pattern of high volatility. The ...

Idorsia Ltd. shares are demonstrating notable strength in today's trading session, propelled by two significant strategic developments that are prompting ...

Shares of the biopharmaceutical firm Idorsia declined by 2.50% yesterday to close at CHF 4.09. This pullback occurred even as ...

Swiss biopharmaceutical firm Idorsia Ltd. finds itself at a pivotal juncture, having successfully navigated a critical financial restructuring while simultaneously ...

A single research report has dramatically shifted market sentiment toward Swiss biopharmaceutical company Idorsia Ltd. A prominent analyst has not ...